| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Norwalk Leslie V is a Director at ARVN with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Director | Sell | 2,000 | $101.10 | $202,200.00 | -16.1% | -2.8% | - | ||
| Dec 16, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 6,190 | $152.78 | $945,701.91 | -31.2% | -12.7% | - | |
| Dec 12, 2025 | Director | Sell | 4,000 | $88.85 | $355,400.00 | -24.4% | -2.5% | - | ||
| Jul 11, 2024 | Director | Sell | 1,000 | $70.00 | $70,000.00 | -5.7% | -0.4% | -19.3% | ||
| May 17, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 1,106 | $141.82 | $156,849.93 | -52.7% | +3.9% | -14.9% | |
| Mar 15, 2024 | Director | Sell | 10,590 | $51.99 | $550,574.10 | -37.8% | +28.2% | +38.2% | ||
| Feb 27, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 8,000 | $135.67 | $1,085,388.00 | -100% | +3.3% | -13.6% |